Aspiro Pharma Limited Voriconazole Export Data — India (DGFT 2022–2026)

Name: Aspiro Pharma Limited Voriconazole Export Records India — #6 Exporter, 59 Shipments, $1.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Voriconazole

India Pharmaceutical Trade Intelligence

$31.3M144 Suppliers114 CountriesHS 30049029

ExportsIndia → CHINA20.0%India → UNITED STATES18.6%

ImportsITALY → India$414.7K FRANCE → India$70.5K

#1 Supplier: SANDOZ PRIVATE

Aspiro Pharma Limited — Voriconazole Exporter #6 | $1.4M Trade Value | TransData Nexus | TransData Nexus

Aspiro Pharma Limited — Voriconazole Exporter Profile

Indian Pharmaceutical Exporter · #6 for Voriconazole · $1.4M export value · DGFT Verified

Aspiro Pharma Limited is the #6 Indian exporter of Voriconazole with $1.4M in export value and 59 verified shipments. Aspiro Pharma Limited holds a 4.5% market share in Voriconazole exports across 15 countries. The company exports 3 pharmaceutical products worth $8.0M across 3 therapeutic categories.

Aspiro Pharma Limited — Voriconazole Export Profile: Buyers & Destinations

Aspiro Pharma Limited Voriconazole export treemap — buyers and destination countries | TransData Nexus

Where Does Aspiro Pharma Limited Export Voriconazole?

Country	Value	Shipments	Share
BRAZIL	$247.3K	6	20.0%
THAILAND	$180.3K	7	14.6%
GAUTEMALA	$166.2K	7	13.4%
INDONESIA	$145.9K	6	11.8%
KAZAKISTAN	$129.8K	7

Who Are the Top Buyers of Voriconazole from Aspiro Pharma Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	BRAZIL	$639.5K	31
CAMBER PHARMACEUTICAL CO., LTD.	THAILAND	$121.6K	4
CAMBER FORMACEUTICA LTDA	BRAZIL	$115.3K	3
TO THE ORDER	KAZAKHSTAN	$68.7K	4
TO THE ORDER OF., .. ,.	INDONESIA	$65.6K	2
PT. AMAROX PHARMA GLOBAL	INDONESIA	$47.6K	3
HETERO DRUGS SOUTH AFRICA (PTY) LTD	SOUTH AFRICA	$46.8K	1
TO THE ORDER OF.,	INDONESIA	$32.7K	1
CAMBER PHARMACEUTICAL CO LTD	THAILAND	$32.3K	1
AMAROX PHARMA, S.A. DE C.V.	MEXICO	$14.5K	1

Aspiro Pharma Limited supplies Voriconazole to 18 buyers globally. The largest buyer is TO THE ORDER OF (BRAZIL), followed by CAMBER PHARMACEUTICAL CO., LTD. (THAILAND) and CAMBER FORMACEUTICA LTDA (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Voriconazole Formulations Does Aspiro Pharma Limited Export?

Product Description / Formulation	Value	Shipments
VORICONAZOLE INJ	$125.3K	5
VORICA VORICONAZOLE VIAL	$124.3K	5
VORICONAZOLE 200MG/VIAL (VZOM)VLS	$115.3K	3
VORICONAZOLE 200MG VIAL (VORICA 200MG) (	$65.6K	2
VORICA 200 VORICONAZOLE 200MG VIAL(2952	$57.4K	2
VZOM VORICONAZOLE 200 VIAL	$50.0K	1
VORICA (VORICONAZOLE 200MG) (4998 PAC)(1	$50.0K	1
ENOIRA VORICONAZOLE 200 VIAL	$50.0K	1
VZOM 200MG VORICONAZOLE 200MG VIAL	$50.0K	1
VORICA VORICONAZOLE	$47.6K	3

Aspiro Pharma Limited exports 37 distinct Voriconazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VORICONAZOLE INJ with 5 shipments worth $125.3K.

How Does Aspiro Pharma Limited Compare to Nearest Voriconazole Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	SANDOZ PRIVATE LIMITED	$7.3M	146	8	$50.0K
3	MSN LABORATORIES PRIVATE LIMITED	$2.5M	100	11	$24.8K
6	ASPIRO PHARMA LIMITED ★	$1.4M	59	15	$23.8K
7	INTAS PHARMACEUTICALS LIMITED	$1.4M	92	14	$15.2K
8	MYLAN LABORATORIES LIMITED	$1.4M	44	6	$31.3K

Aspiro Pharma Limited ranks #6 among 144 Indian Voriconazole exporters. Average shipment value of $23.8K compared to the market average of $135.8K. The closest competitors by value are SANDOZ PRIVATE LIMITED and MSN LABORATORIES PRIVATE LIMITED.

Which Indian Ports Ship Voriconazole Exports?

Port	Shipments	% Share
SAHAR AIR	256	18.1%
SAHAR AIR CARGO ACC (INBOM4)	194	13.7%
DELHI AIR CARGO ACC (INDEL4)	112	7.9%
DELHI AIR	103	7.3%
HYDERABAD AIR	68	4.8%
Bombay Air	55	3.9%
HYDERABAD ACC (INHYD4)	49	3.5%
HYDERABAD ICD (INSNF6)	39	2.8%

Geopolitical & Trade Policy Impact on Aspiro Pharma Limited's Voriconazole Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Aspiro Pharma. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These logistical challenges can impact the timely delivery of pharmaceuticals, which is critical for maintaining supply chain integrity and meeting contractual obligations. (pharmaceuticalcommerce.com)

Conversely, the US-China trade tensions have opened avenues for Indian exporters to fill the gap left by Chinese suppliers. Aspiro Pharma can leverage this opportunity by strengthening its presence in the US market, especially given India's existing supply of 40% of the US's generic drug needs. (ibef.org) However, potential US tariffs on pharmaceutical imports necessitate a cautious approach, as they could affect pricing strategies and profit margins. (business-standard.com)

The recent India-European Union Free Trade Agreement (FTA) signed in January 2026 is another significant development. The FTA aims to eliminate tariffs on pharmaceuticals, potentially enhancing market access for Indian exporters. Aspiro Pharma should monitor the implementation of this agreement to capitalize on reduced trade barriers and expand its footprint in the European market. (en.wikipedia.org)

Aspiro Pharma Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is a cornerstone for success in pharmaceutical exports. India has made significant strides in this area, surpassing the US in the number of FDA-registered generic manufacturing sites, with 752 FDA-approved facilities as of 2024. (business-standard.com) For Aspiro Pharma, maintaining stringent quality control measures and adhering to Good Manufacturing Practices (GMP) are essential to ensure continued access to regulated markets.

The European Union's Falsified Medicines Directive (FMD) imposes additional requirements for traceability and verification of pharmaceutical products. Aspiro Pharma must ensure compliance with these regulations to prevent counterfeit medicines from entering the supply chain and to maintain trust with European partners.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Voriconazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Aspiro Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 59 individual customs records matching Aspiro Pharma Limited exporting Voriconazole, covering 37 formulations to 17 countries via 18 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 114+ countries, 393+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Voriconazole

Voriconazole

Aspiro Pharma Limited — Voriconazole Exporter Profile

Aspiro Pharma Limited — Voriconazole Export Profile: Buyers & Destinations

Where Does Aspiro Pharma Limited Export Voriconazole?

Who Are the Top Buyers of Voriconazole from Aspiro Pharma Limited?

What Is India's Total Voriconazole Export Value and How Much Does Aspiro Pharma Limited Contribute?

What Is the Average Shipment Value for Aspiro Pharma Limited's Voriconazole Exports?

How Does Aspiro Pharma Limited Compare to Other Indian Voriconazole Exporters?

What Voriconazole Formulations Does Aspiro Pharma Limited Export?

Regulatory Requirements: Exporting Voriconazole to Key Markets

Brazil — ANVISA

How Does Aspiro Pharma Limited Compare to Nearest Voriconazole Exporters?

Which Indian Ports Ship Voriconazole Exports?

Geopolitical & Trade Policy Impact on Aspiro Pharma Limited's Voriconazole Exports

Aspiro Pharma Limited — Regulatory Compliance & Quality Standards

About Aspiro Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Voriconazole Export Data from Aspiro Pharma Limited

Voriconazole Stats

Company Overview

Top Products by Aspiro Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source